Atlanta Behavioral Research, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Bipolar disorder2 trials
• Depression2 trials
• Schizophrenia2 trials
• Autism1 trial
• Tourette syndrome1 trial

Phase

• Phase 34 trials
• Phase 41 trial

Status

• Completed4 trials
• Terminated1 trial
• Withdrawn1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Emalex Biosciences Inc.1 trial
• Gedeon Richter Plc.1 trial
• Intra-Cellular Therapies, Inc.1 trial
• Sumitomo Pharma America, Inc.1 trial

Closed trials

• Recruiting

  Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  NCT06229210· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Completed

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Source

• Completed

  Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

  NCT05615220· Phase 3· Emalex Biosciences Inc.· Source

• Terminated

  A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

  NCT05227209· Phase 3· Sumitomo Pharma America, Inc.· Source

• Completed

  A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

  NCT04599855· Phase 4· Janssen Research & Development, LLC· Source

• Recruiting

  Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  NCT03817502· Phase 3· Gedeon Richter Plc.· Source

  Contact: Balázs Lázár